Neocopride

hAChE inhibitor IC50 73 nM (hBuChE inhibition 51% at 105M); agonist of the h5-HT4 receptor Ki of 48 nM

General

Type : Cycloheptyl, Piperidine, Multitarget, 5-HT-receptor-ligand

Chemical_Nomenclature : 1-(4-amino-5-fluoro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)piperidin-4-yl]propan-1-one

Canonical SMILES : COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CC3CCCCCC3)F)N

InChI : InChI=1S\/C23H35FN2O2\/c1-28-23-15-21(25)20(24)14-19(23)22(27)9-8-17-10-12-26(13-11-17)16-18-6-4-2-3-5-7-18\/h14-15,17-18H,2-13,16,25H2,1H3

InChIKey : HKRQNSWIPOUSMA-UHFFFAOYSA-N

Other name(s) : MR36014  ||  SCHEMBL21866064


MW : 390.5

Formula : C23H35FN2O2

CAS_number :

PubChem : 146493768

UniChem : HKRQNSWIPOUSMA-UHFFFAOYSA-N

Target

Families : Neocopride ligand of proteins in family
ACHE

Protein :
human-ACHE

References (1)

Title : An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride - Rochais_2026_J.Alzheimers.Dis__13872877261424925
Author(s) : Rochais C , Lecoutey C , Culley G , Curel T , Davis A , Duval E , Rouviere L , Henriques A , Legrand R , Claeysen S , Callizot N , Dallemagne P
Ref : J Alzheimers Dis , :13872877261424925 , 2026
Abstract :
PubMedSearch : Rochais_2026_J.Alzheimers.Dis__13872877261424925
PubMedID: 41823649